Tower Research Capital »

Bridgebio Pharma shares owned by Tower Research Capital

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $852k 34k 25.33
2024-03-31 $40k 1.3k 30.92
2023-09-30 $52k 2.0k 26.36
2023-06-30 $244k 14k 17.20
2023-03-31 $72k 4.4k 16.49
2022-12-31 $50k 6.5k 7.75
2022-09-30 $167k 17k 9.96
2022-06-30 $296k 33k 9.03
2022-03-31 $180k 18k 10.23
2021-12-31 $275k 17k 16.64
2021-09-30 $554k 12k 46.80
2021-06-30 $326k 5.3k 60.97
2021-03-31 $468k 7.6k 61.69
2020-12-31 $178k 2.5k 72.00
2020-09-30 $127k 3.4k 37.58
2020-06-30 $775k 24k 32.60
2019-12-31 $38k 1.1k 34.64
2019-09-30 $10k 463 21.60